Zydus Lifesci.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
933.10
-2.1 (-0.22%)
BSENSE

Dec 05

BSE+NSE Vol: 9.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
6,123.20
6,573.70
6,527.90
5,269.10
5,237.00
6,207.50
5,533.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,123.20
6,573.70
6,527.90
5,269.10
5,237.00
6,207.50
5,533.80
Raw Material Cost
1,327.10
1,218.90
1,164.40
1,026.50
1,066.50
1,115.50
1,210.30
Purchase of Finished goods
589.10
658.20
572.60
571.10
483.90
522.40
542.90
(Increase) / Decrease In Stocks
-225.70
-87.60
-39.90
-14.20
-79.00
-51.80
-141.70
Employee Cost
1,034.20
1,005.20
971.40
946.50
879.20
883.50
837.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,382.70
1,690.50
1,733.90
1,351.60
1,425.00
1,653.90
1,454.80
Total Expenditure (Excl Depreciation)
4,107.40
4,485.20
4,402.40
3,881.50
3,775.60
4,123.50
3,903.30
Operating Profit (PBDIT) excl Other Income
2,015.80
2,088.50
2,125.50
1,387.60
1,461.40
2,084.00
1,630.50
Other Income
109.00
154.90
80.60
57.50
68.20
63.20
156.40
Operating Profit (PBDIT)
2,124.80
2,243.40
2,206.10
1,445.10
1,529.60
2,147.20
1,786.90
Interest
101.30
84.70
76.60
32.00
25.10
32.20
34.60
Exceptional Items
-34.20
0.00
-219.60
-0.30
0.30
0.00
3.20
Gross Profit (PBDT)
1,989.30
2,158.70
1,909.90
1,413.10
1,504.50
2,115.00
1,752.30
Depreciation
301.90
238.10
237.90
229.00
233.60
215.30
205.30
Profit Before Tax
1,687.40
1,920.60
1,672.00
1,184.10
1,270.90
1,899.70
1,547.00
Tax
454.00
434.00
423.20
179.50
373.10
436.10
321.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,233.40
1,486.60
1,248.80
1,004.60
897.80
1,463.60
1,225.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
-0.30
0.30
0.00
3.20
Net Profit
1,233.40
1,486.60
1,248.80
1,004.30
898.10
1,463.60
1,229.00
Share in Profit of Associates
5.20
34.40
-5.10
21.90
22.10
18.90
17.10
Minority Interest
-20.00
54.20
72.80
2.70
9.00
62.60
63.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,258.60
1,466.80
1,170.90
1,023.50
911.20
1,419.90
1,182.30
Equity Capital
100.60
100.60
100.60
100.60
100.60
100.60
100.60
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.51
14.58
11.64
10.17
9.06
14.11
11.75
Diluted Earnings per share
12.51
14.58
11.64
10.17
9.06
14.11
11.69
Operating Profit Margin (Excl OI)
33.39%
32.29%
33.79%
27.08%
28.58%
34.47%
30.38%
Gross Profit Margin
32.95%
33.38%
30.36%
27.58%
29.42%
34.98%
32.65%
PAT Margin
20.43%
22.99%
19.85%
19.61%
17.56%
24.21%
22.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 16.92% vs 19.87% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 38.13% vs 13.80% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 37.94% vs 27.51% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 303.59% vs 188.51% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Zydus Lifesci. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
6,123.20
7,047.51
-924.31
-13.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,123.20
7,047.51
-924.31
-13.12%
Raw Material Cost
1,327.10
1,139.15
187.95
16.50%
Purchase of Finished goods
589.10
724.92
-135.82
-18.74%
(Increase) / Decrease In Stocks
-225.70
-39.30
-186.40
-474.30%
Employee Cost
1,034.20
1,105.56
-71.36
-6.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,382.70
1,775.85
-393.15
-22.14%
Total Expenditure (Excl Depreciation)
4,107.40
4,706.18
-598.78
-12.72%
Operating Profit (PBDIT) excl Other Income
2,015.80
2,341.33
-325.53
-13.90%
Other Income
109.00
90.00
19.00
21.11%
Operating Profit (PBDIT)
2,124.80
2,431.33
-306.53
-12.61%
Interest
101.30
107.59
-6.29
-5.85%
Exceptional Items
-34.20
0.00
-34.20
Gross Profit (PBDT)
1,989.30
2,323.74
-334.44
-14.39%
Depreciation
301.90
316.77
-14.87
-4.69%
Profit Before Tax
1,687.40
2,006.97
-319.57
-15.92%
Tax
454.00
522.14
-68.14
-13.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,233.40
1,484.83
-251.43
-16.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,233.40
1,484.83
-251.43
-16.93%
Share in Profit of Associates
5.20
0.00
5.20
Minority Interest
-20.00
6.91
-26.91
-389.44%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,258.60
1,477.92
-219.32
-14.84%
Equity Capital
100.60
91.36
9.24
10.11%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.51
32.35
-19.84
-61.33%
Diluted Earnings per share
12.51
32.28
-19.77
-61.25%
Operating Profit Margin (Excl OI)
33.39%
34.27%
0.00
-0.88%
Gross Profit Margin
32.95%
34.02%
0.00
-1.07%
PAT Margin
20.43%
21.74%
0.00
-1.31%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 6,123.20 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.85% vs 0.70% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 16.92% vs 19.87% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,258.60 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -14.19% vs 25.27% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 38.13% vs 13.80% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,015.80 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.48% vs -1.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 37.94% vs 27.51% in Sep 2024

Quarterly - Interest
Interest 101.30 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 19.60% vs 10.57% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 303.59% vs 188.51% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.39%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024